Meloxicam Bioveta 1.5 mg/g, oral suspension

Homepage Products Veterinary products Meloxicam Bioveta 1.5 mg/g, oral suspension

Composition (1 ml)

Meloxicamum                                   1.5 mg

Target species

Dogs

Indication

To suppress the process of inflammation and alleviation of pain (post-traumatic or post-surgical alleviation of pain).

Route of administration and dosage

Oral administration in feed or directly into the mouth.

Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight, i.e. 1 ml of the product to 7.5 kg body weight on the first day.

Treatment should be continued by administration of a maintenance dose of 0.1 mg meloxicam/kg body weight (1 ml of the product/15 kg bw) once daily at 24-hour intervals.
For longer term treatment, once a clinical response has been observed (after ≥ 4 days), the dose of the product can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculoskeletal disorders may vary over time.

A clinical response is normally seen within 3-4 days. Treatment should be discontinued after 10 days, at the latest, if no clinical improvement is apparent.

Alternatively, therapy may be initiated with MELOXICAM Bioveta 5 mg/ml solution for injection.

Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Do not use in dogs under 6 weeks of age.

Storage

Store at temperatures below 25 °C.

Protect from light.

Do not freeze.

Shelf life

24 months.

Once opened, 6 months.

Package

15 ml.